Growing community of inventors

Summerset, NJ, United States of America

Kevin Czaplinski

Average Co-Inventor Count = 3.33

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Kevin CzaplinskiStuart W Peltz (5 patents)Kevin CzaplinskiHolger Beckmann (2 patents)Kevin CzaplinskiJonathan D Dinman (2 patents)Kevin CzaplinskiMarc Learned (2 patents)Kevin CzaplinskiYoumin Weng (1 patent)Kevin CzaplinskiKevin Czaplinski (5 patents)Stuart W PeltzStuart W Peltz (7 patents)Holger BeckmannHolger Beckmann (7 patents)Jonathan D DinmanJonathan D Dinman (3 patents)Marc LearnedMarc Learned (2 patents)Youmin WengYoumin Weng (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Other (2 from 833,002 patents)

2. University of Medicine and Dentistry of New Jersey (2 from 272 patents)

3. Ptc Therapeutics, Inc. (1 from 184 patents)


5 patents:

1. 7026122 - Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay

2. 6989256 - Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof

3. 6630294 - Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof

4. 6486305 - METHOD OF MODULATING THE EFFICIENCY OF TRANSLATION TERMINATION AND DEGRADATION OF ABERRANT MRNA INVOLVING A SURVEILLANCE COMPLEX COMPRISING HUMAN UPF1P, EUCARYOTIC RELEASE FACTOR 1 AND EUCARYOTIC RELEASE FACTOR 3

5. 6458538 - Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/21/2026
Loading…